Program areas at BRI
Biomedical Research and disease investigations, including dna synthesis and cell analysis. Beckman Research Institute has pioneered scientific breakthroughs resulting in treatments that have improved the lives of patients worldwide. Numerous life-saving drugs use patented technology developed at Beckman Research Institute. These drugs include synthetic human insulin (humulin) for diabetes, the widely used cancer drugs herceptin, rituxan and avastin, and humira for arthritis. Researchers at Beckman Research Institute undertake fundamental investigations in diabetes progression and treatment, immunology and imaging, interfering rnas and hiv treatment, total synthesis of complex and therapeutic natural products, mechanisms of drug action, neurogenesis, stem cell therapy, dna repair and radiation, and the immunobiology of viral infection. They have achieved major advances in recombinant dna technology, monoclonal antibodies, gene therapy, epigenetics, si-rna technology and cancer immunotherapeutics. A department in Beckman Research Institute is dedicated to understanding and developing treatments based on cancer's interaction with the immune system. Other Research has identified proteins that may play critical roles in immune response and may lead to new treatment strategies. Another major emphasis for the Beckman Research Institute scientists is personalized Research and medicine -- analyzing a patient's unique genetic profile to develop tailored therapies for their specific disease. All of this Research is uniquely supported by onsite manufacturing facilities that can test and produce quantities of cell-based, gene-based and molecular therapies. These facilities further serve as resources for medical and scientific Research centers nationwide. Beckman Research Institute scientists serve as faculty members in City of Hope's irell & manella graduate school of biological sciences. the graduate school's mission is to train students to be outstanding Research scientists in chemical, molecular and cellular biology. the school is accredited by the western association of schools and colleges. Graduates of the program, awarded a doctorate of philosophy in biological sciences, are equipped to address fundamental questions in life sciences and biomedicine for careers in academia, industry and government.
Who funds Beckman Research Institute of the City of Hope (BRI)
Grants from foundations and other nonprofits
Personnel at BRI
Name | Title | Compensation | Date of data |
---|
Robert Stone | Chief Executive Officer | $1,079,108 | 2024-10-03 |
Angelique L. Richard, Ph.D., R.N. | Chief Operating Officer , City of Hope National Medical Center | | 2024-10-03 |
Yvette Tremonti | Treasurer and Chief Financial Officer | | 2024-08-13 |
Ken Chaplin | System Chief Marketing Officer | | 2024-10-03 |
Simon Nazarian | System Executive Vice President and Chief Digital and Technology Officer | | 2024-10-03 |
...and 24 more key personnel |
Financials for BRI
Revenues | FYE 09/2023 | FYE 09/2022 | % Change |
---|
Total grants, contributions, etc. | $150,737,172 | $154,152,878 | -2.2% |
Program services | $15,969,208 | $25,203,801 | -36.6% |
Investment income and dividends | $13,528,631 | $14,429,552 | -6.2% |
Tax-exempt bond proceeds | $0 | $0 | - |
Royalty revenue | $8,998,487 | $12,755,042 | -29.5% |
Net rental income | $61,700 | $86,500 | -28.7% |
Net gain from sale of non-inventory assets | $35,158,934 | $79,091,943 | -55.5% |
Net income from fundraising events | $0 | $0 | - |
Net income from gaming activities | $0 | $0 | - |
Net income from sales of inventory | $0 | $0 | - |
Miscellaneous revenues | $4,632,402 | $2,556,297 | 81.2% |
Total revenues | $229,086,534 | $288,276,013 | -20.5% |
Organizations like BRI
Organization | Type | Location | Revenue |
---|
American Association for Cancer Research | 501(c)(3) | Philadelphia, PA | $74,316,369 |
Fred Hutch (FHCRC) | 501(c)(3) | Seattle, WA | $696,845,474 |
Texas Biomedical Research Institute | 501(c)(3) | San Antonio, TX | $65,045,950 |
Baylor Scott & White Research Institute | 501(c)(3) | Dallas, TX | $73,307,762 |
The Lundquist Institute | 501(c)(3) | Torrance, CA | $91,625,062 |
La Jolla Institute for Immunology (LIAI) | 501(c)(3) | La Jolla, CA | $92,274,481 |
Benaroya Research Institute at Virginia Mason | 501(c)(3) | Seattle, WA | $82,465,243 |
Van Andel Research Institute | 501(c)(3) | Grand Rapids, MI | $143,778,282 |
Whitehead Institute for Biomedical Research | 501(c)(3) | Cambridge, MA | $120,192,597 |
Jackson Laboratory | 501(c)(3) | Bar Harbor, ME | $553,515,570 |
Data update history
September 24, 2024
Posted financials
Added Form 990 for fiscal year 2023
September 22, 2024
Used new vendors
Identified 2 new vendors, including , and
September 21, 2024
Updated personnel
Identified 3 new personnel
September 21, 2024
Received grants
Identified 15 new grant, including a grant for $43,883,442 from City of Hope Nonprofit Types
Medical research organizationsResearch centersHeadquarter / parent organizationsCharities
Issues
Science and technologyHealthDiseases and disorders
Characteristics
Conducts researchLobbyingOperates internationallyReceives government fundingEndowed supportTax deductible donations
General information
- Address
- 1450 E Duarte Rd
- Duarte, CA 91010
- Metro area
- Los Angeles-Long Beach-Anaheim, CA
- County
- Los Angeles County, CA
- Phone
- (626) 256-4673
IRS details
- EIN
- 95-3432210
- Fiscal year end
- September
- Taxreturn type
- Form 990
- Year formed
- 1979
- Eligible to receive tax-deductible contributions (Pub 78)
- Yes
Categorization
- NTEE code, primary
- H30: Cancer Research
- NAICS code, primary
- 5417: Scientific Research and Development Services
- Parent/child status
- Central organization
Free account sign-up
Want updates when BRI has new information, or want to find more organizations like Beckman Research Institute of the City of Hope (BRI)?
Create free Cause IQ account